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Abstract
Background: The tuberculosis (TB) still increases in the number of new cases, which is estimated to approach 10
million in 2010. The number of aged people has been growing all over the world. Ageing is one of risk factors in
tuberculosis because of decreased immune responses in aged people. Mycobacterium bovis Bacillus Calmette
Guérin (BCG) is a sole vaccine currently used for TB, however, the efficacy of BCG in adults is still a matter of
debate. Emerging the multidrug resistant Mycobacterium tuberculosis (MDR-TB) make us to see the importance of
vaccination against TB in new light. In this study, we evaluated the efficacy of BCG vaccination in aged mice.
Results: The Th1 responses, interferon-g production and interleukin 2, in BCG inoculated aged mice (24-month-old)
were comparable to those of young mice (4- to 6-week-old). The protection activity of BCG in aged mice against
Mycobacterium tuberculosis H37Rv was also the same as young mice.
Conclusion: These findings suggest that vaccination in aged generation is still effective for protection against
tuberculosis.
Introduction
The number of aged people has been increasing all over
the world. World health organization reported that the
increase rate of the number was 28% in the recent dec-
ade (2000 to 2009), and predicted that the number
would reach 1.5 billion by 2050 [1]. The largest popula-
tion of aged people (predicted to be 78% by the year
2050) resides in developing countries [1], where many
infectious diseases, including tuberculosis (TB) [2], are
endemic. Given the increased susceptibility of the
elderly to infectious diseases, the rapid rise in the elderly
population will become a significant threat to global
health care.
The current TB vaccine is the live attenuated bacterium
Mycobacterium bovis Bacillus Calmette Guérin (BCG).
BCG is known to protect against tuberculous meningitis
in babies children. However, it does not efficiently and
consistently protect against pulmonary TB in adults.
Over the years, many hypotheses have been put forward
to explain the apparent variability in the protective
efficacy of BCG, which varies from 0 to 80% [3].
Explanations for this inconsistency include differences in
trial methodology, host population genetics, use of differ-
ent BCG vaccine strains [4], and heterogeneous immunity
to a variety of environmental mycobacteria that may
interfere with the protection provided by BCG [5,6]. We
have previously reported that ‘early shared BCG strains’
(ex. BCG-Russia, BCG-Moreau, BCG-Japan), which are
chronologically early strains distributed form Pasteur
Institute, conserve the characteristics of authentic BCG
vaccine [7,8]. Immune response profiles following BCG
vaccination comprise myriads of effecter mechanisms,
multiple T-cell subsets, and many targeted antigens. BCG
is capable of inducing Th1 responses [9], which are criti-
cal for protection against mycobacterial infection [10].
As an individual ages, significant immunological
changes occur, which contribute to the enhanced mor-
bidity and mortality associated with infectious diseases
in the elderly. After puberty, thymic atrophy leads to a
progressive decrease in the output of naïve T cells and
decreased diversity in the T-cell repertoire [11]. CD8
+
T cells play an important role in innate response to
pathogen such as M. tuberculosis in the aged mouse
[12,13]. In this study, the efficacy of vaccination with
BCG in aged mice was investigated.
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Specific-pathogen-free female C57BL/6 mice were sup-
plied from the national center for geriatrics and geron-
tology (SLC, Japan). Young mice were 4- to 6-week of
age, and old mice were 24-month of age. CD4/CD8 T
cell ratio decreased by aging (Table 1), which is similar
to previous reports [14,15]. Mice were vaccinated intra-
peritoneally with 10
6 colony forming unit (CFU) of M.
bovis BCG Japan (Tokyo172) in 0.1 ml saline. The
immunized mice were infected intravenously with 10
5
CFU M. tuberculosis strain H37Rv (ATCC 25618). To
assess mycobacterial multiplication in spleen and lung,
0.1 ml of serial 10-fold dilutions of whole-organ 2-ml
homogenates were plated onto Middlebrook 7H11 agar
containing 10% OADC, and colonies were counted after
18-20 days post incubation at 37°C.
Th1 type cytokines are known to play an important
role in the cellular type immune response in tuberculo-
sis [16,17]. We investigated whether the Th1 cytokines
were induced by BCG vaccination. The productions of
interferon (IFN)-g and interleukin (IL)-2 from spleno-
cytes stimulated with purified protein derivatives (PPD)
were elevated in both BCG vaccinated young (4- to 6-
month-old) and aged mice (24-month-old), but not in
non vaccinated mice (Figure 1). These results indicate
that BCG vaccination can induce Th1 responses in aged
mice comparable to young mice.
In order to avoid the effects of cytokines induced by
BCG vaccination on infection of M. tuberculosis,t h e
levels of cytokines (IL-6, IL-10, IL-12p70, monocyte che-
motactic protein (MCP)-1, IFN-g, tumor necrosis factor
(TNF)-a) in the serum from BCG vaccinated young
mice were measured by Cytometric Beads Array (CBA)
Table 1 T cell subsets in the peripheral blood of young
and aged mice
a
CD4 CD8 CD4/CD8
Young (4-6-week) 12.9 ± 6.55 17.3 ± 9.23 1.33 ± 0.66
Aged (24-month) 5.5 ± 1.83 6.2 ± 0.37 0.56 ± 0.28
a PBMC were stained with FITC-labeled anti-CD4 and PE-labeled anti-CD8
mAbs (BD Biosciences) and analyzed by FACScan. Data represent mean ± of
three mice.
Figure 1 BCG vaccination to young and aged mice augments Th1 cytokine production by PPD stimulated splenocytes. Young (a, c) and
aged (b, d) mice were immunized with 1 × 10
6 CFU of BCG or phosphate buffered saline (PBS). Eight weeks after immunization, the animals
were intravenously challenged with 1 × 10
5 CFU of M. tuberculosis strain H37Rv. Four weeks after challenge, the levels of IL-2 (a, b) and IFN-g (c,
d) in the culture supernatants of splenocytes stimulated with PBS (open column) or PPD (solid column) were measured by ELISA (BD
Biosciences). Data represent mean ± SD of three mice. *, p < 0.05, compared with PBS-stimulation (student’s t-test).
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and IFN-g increased at 1 week post-inoculation, and
returned to the basal level at 2 to 4 weeks. IL-6, TNF,
MCP-1 peaked at two weeks after inoculation, and
returned to the basal level at 4 weeks (data not shown).
Therefore, the infection experiments were conducted six
weeks after inoculation.
To confirm the inoculation of BCG and infection of
M. tuberculosis, the level of serum antibody against PPD
was measured by ELISA. The level of the antibody ele-
vated two weeks after BCG inoculation, peaked at
4 weeks and returned to the basal level at 6 weeks.
After infection of M. tuberculosis the level was elevated
again (data not shown). Body weights of young mice
slightly increased according to their growth, while those
of aged mice slightly decreased (data not shown). The
changes in body weight of young and aged vaccinated-
mice were the same as those of non-vaccinated mice.
Vaccinated mice grew normally, and death was not
observed in both young and aged mice. Therefore, vacci-
nation of BCG would be safe to both young and aged
mice. Eight weeks after inoculation of BCG, mice were
infected with M. tuberculosis H37Rv intravenously. Four
weeks after infection the mice were killed and colony
assay for bacterial count in the organs (lung and liver)
from young and aged mice was performed (Figure 2).
The bacterial numbers in both young and aged mice
were reduced. These data indicate that BCG vaccination
could induce the protection against M. tuberculosis in
aged mice to the same degree as young mice.
Conclusion
In conclusion, this is a first report to evaluate the effi-
cacy of BCG vaccination in aged (24-month-old) mice
as compared to young (4- to 6-week-old) mice. BCG
inoculation induced Th1 type immune responses in
both young and aged mice (Figure 1). The protection
activity was observed in aged mice, which was compar-
able to young mice (Figure 2). Our study suggests that
vaccination in aged people could be effective to prevent
infection against tuberculosis.
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Figure 2 BCG protects both young and aged mice against M. tuberculosis infection. Young (a) and aged (b) mice were immunized with 1
×1 0
6 CFU of BCG (solid column) or PBS (open column). Eight weeks after immunization, the mice were intravenously challenged with 1 × 10
5
CFU of M. tuberculosis strain H37Rv. Four weeks after challenge, the bacterial numbers in the lung and spleen were determined by colony assay.
Data represent mean ± SD of three mice. *, p < 0.05, compared with PBS-inoculated control group (student’s t-test).
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